郁芩利胆汤联合熊去氧胆酸预防内镜微创保胆取石术后结石复发临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R269

基金项目:

深圳市龙岗区医疗卫生科技计划项目(LGWJ2021-079)


Clinical Study on Yuqin Lidan Decoction Combined with Ursodeoxycholic Acid in Preventing Gallstone Recurrence After Endoscopic Minimally Invasive Gallbladder- Preserving Lithotomy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察郁芩利胆汤联合熊去氧胆酸预防内镜微创保胆取石术后结石复发的临床效果。方法: 选取2020年1月—2022年2月在北京中医药大学深圳医院(龙岗) 普通外科治疗的71例行内镜保胆取石术内 镜保胆取石术的胆囊结石患者,按随机数字表法分成西药组、中药组、中西药组。3组均行内镜微创保胆取石 术,预防结石复发治疗从术后14天开始至术后6个月,随访至术后24个月。西药组给予熊去氧胆酸胶囊治疗, 中药组给予郁芩利胆汤治疗,中西药组给予郁芩利胆汤联合熊去氧胆酸胶囊治疗,比较3组术后6~24个月的 胆囊壁厚度、胆囊收缩率、消化病生存质量指数(GIQLI) 评分和血清胆囊收缩素(CCK)、人胃动素(MTL)、 甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白(HDL) 水平;比较3组胆结石复发率、不良反应发生率。 结果:术后6个月、12个月、24个月,3组胆囊壁厚度均较术前变薄(P<0.05);术后6个月、12个月中西药 组胆囊壁均薄于同期西药组,西药组胆囊壁薄于同期中药组(P<0.05);术后24个月,3组胆囊壁厚度比较, 差异无统计学意义(P>0.05)。术后6个月、12个月、24个月,3组胆囊收缩率均较术前升高(P<0.05);术 后6个月、12个月,中西药组和西药组胆囊收缩率同期比较,差异均无统计学意义(P>0.05);中西药组和西 药组胆囊收缩率均高于同期中药组(P<0.05);术后24 个月,中西药组胆囊收缩率均高于西药组和中药 组(P<0.05),西药组和中药组胆囊收缩率比较,差异无统计学意义(P>0.05)。术后6个月、术后12个月、 术后24个月,3组GIQLI评分均较术前升高,中西药组GIQLI评分均高于同期西药组和中药组(P<0.05);西 药组GIQLI评分与中药组同期比较,差异均无统计学意义(P>0.05)。术后6个月,3组TG、TC水平均较术前 降低(P<0.05),3 组HDL 水平均较治疗前升高(P<0.05),中西药组TG 水平低于西药组(P<0.05),西 药组TG 水平低于中药组(P<0.05);3 组TC、HDL水平比较,差异均无统计学意义(P>0.05)。术后6个 月,3组CCK、MTL水平均较术前升高(P<0.05),中西药组CCK、MTL水平均高于西药组(P<0.05),西药 组CCK、MTL水平均高于中药组(P<0.05)。术后6个月,3组胆囊结石均无复发;术后12个月,3组复发率 比较,差异无统计学意义(P>0.05);术后24个月,中西药组复发率为0,均低于西药组14.29%,中药组 18.18%(P<0.05);中药组与西药组复发率同期比较,差异均无统计学意义(P>0.05)。3组不良反应发生率 比较,差异均无统计学意义(P>0.05)。结论:郁芩利胆汤联合熊去氧胆酸胶囊预防内镜保胆取石术后结石复 发可促进胆囊功能恢复,持续改善术后胆囊收缩率,降低术后胆囊结石复发率,且未显著增加不良反应。

    Abstract:

    Abstract: Objective: To observe the effect of Yuqin Lidan Decoction combined with Ursodeoxycholic Acid in preventing gallstone recurrence after endoscopic minimally invasive gallbladder-preserving lithotomy. Methods: A total of 71 patients with gallbladder stones who were treated in the General Surgery of Shenzhen Hospital (Longgang) of Beijing University of Chinese Medicine from January 2020 to February 2022 were selected and divided into the western medicine group, the Chinese medicine group, and the combination group according to the random number table method. All the three groups underwent endoscopic minimally invasive gallbladder-preserving lithotomy. The treatment for preventing gallstone recurrence started from the 14th day after surgery and continued for 6 months,folllow-up was conducted up to 24 months postoperatively. The western medicine group was treated with Ursodeoxycholic Acid Capsules,the Chinese medicine group with Yuqin Lidan Decoction,and the combined group with both Yuqin Lidan Decoction and Ursodeoxycholic Acid Capsules. The gallbladder wall thickness, gallbladder contraction rates, Gastrointestinal Quality of Life Index (GIQLI) scores,and serum levels of cholecystokinin (CCK),motilin (MTL), triglycerides( TG),total cholesterol( TC),and high-density lipoprotein( HDL) were compared among the three groups at 6,12,and 24 months postoperatively. The recurrence rate of gallstones and the incidence of adverse reactions were compared among the three groups. Results:At 6,12,and 24 months postoperatively,the gallbladder wall thickness in the three groups was thinner than that before surgery (P<0.05). At 6 and 12 months postoperatively,the gallbladder wall in the combination group was thinner than that in the western medicine group at the same time points, and the gallbladder wall in the western medicine group was thinner than that in the Chinese medicine group (P<0.05). At 24 months postoperatively, there was no significant difference in gallbladder wall thickness among the three groups (P>0.05). The gallbladder contraction rate in all the three groups increased compared to that before surgery at 6, 12,and 24 months postoperatively (P<0.05). At 6 and 12 months postoperatively,there was no significant difference in gallbladder contraction rates between the combination group and the western medicine group at the same time points (P>0.05). However,the gallbladder contraction rates in both the combination group and the western medicine group were higher than that in the Chinese medicine group at the same time points (P<0.05). At 24 months postoperatively,the gallbladder contraction rate in the combination group was higher than those in the western medicine group and the Chinese medicine group (P<0.05), while there was no significant difference between the western medicine group and the Chinese medicine group (P>0.05). At 6, 12 and 24 months after surgery, the GIQLI scores of the three groups were all higher than that before surgery, and the GIQLI scores of the combination groups were higher than those of the western medicine group and the Chinese medicine group in the same period (P<0.05); the differences between the GIQLI scores of the Chinese medicine group and the western medicine group in the same period were not statistically significant (P>0.05). At 6 months postoperatively,the TG and TC levels in all the three groups decreased compared to those before surgery (P<0.05),the HDL levels in all three groups increased compared to those before surgery with the TG level in the combination group being lower than that in the western medicine group (P< 0.05),and the TG level in the western medicine group being lower than that in the Chinese medicine group (P<0.05). There was no significant difference in TC and HDL levels among the three groups (P>0.05). At 6 months postoperatively,the CCK and MTL levels in all the three groups increased compared to those before surgery (P<0.05), with the CCK and MTL levels in the combination group being higher than those in the western medicine group (P< 0.05),and the CCK and MTL levels in the western medicine group being higher than those in the Chinese medicine group (P<0.05). No recurrence was observed in all three groups at 6 months postoperatively. There was no significant difference in the recurrence rates among the three groups at 12 months postoperatively (P>0.05). At 24 months postoperatively,the recurrence rate in the combination group was 0%,which was lower than the 14.29% in the western medicine group and the 18.18% in the Chinese medicine group (P<0.05). There was no significant difference in the recurrence rate between the Chinese medicine group and the western medicine group (P>0.05). There was no significant difference in the incidence of adverse reactions among the three groups (P>0.05). Conclusion: The combination of Yuqin Lidan Decoction and Ursodeoxycholic Acid in preventing gallstone recurrence after endoscopic minimally invasive gallbladder-preserving lithotomy can better promote the recovery of gallbladder function, continuously improve the postoperative gallbladder contraction rates, and reduce the postoperative recurrence rate of gallstones without significantly increasing adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

李斌,陈卫民,赖淑贵,孟庆军,艾小刚,董晓晨,李小华,叶世青.郁芩利胆汤联合熊去氧胆酸预防内镜微创保胆取石术后结石复发临床研究[J].新中医,2025,57(13):54-60

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-07-14
  • 出版日期:
文章二维码